However, there is a form of breast cancer that expresses neither hormone receptors nor HER2 receptors, thereby limiting the treatment options to standard therapy in these patients, i.e. surgery, radiotherapy and chemotherapy. This evidence concerns the gene NR4A1 and breast carcinoma.